Table 2.

Clinical characteristics and body composition at baseline and after 12 weeks of intervention (Medians and 25th–75th percentiles)

	High ALA-DAG (n 10)					High ALA-TAG (n 13)
	Baseline		End of study			Baseline		End of study
	Median	25th–75th percentiles	Median	25th–75th percentiles	P*	Median	25th–75th percentiles	Median	25th–75th percentiles	P†	P‡
Sex (n)
Male	6					11
Female	4					2
Age (years)	57	45–65				52	43–60				0·1
Systolic BP (mmHg)	135	121–144	126	121–136	0·05	136	126–154	141	134–149	0·2	0·05
Diastolic BP (mmHg)	81	77–88	79	76–92	1·0	83	77–89	87	84–91	0·1	0·2
Weight (kg)	86·3	80·2–102·9	87·2	80·9–104·1	0·07	95·9	91·7–106·9	97.5	91·6–106·0	1·0	0·3
BMI (kg/m2)	29	28–31	29	28–32	0·2	31	30–33	31	30–33	0·7	0·2
Waist (cm)	99	96–109	99	96–107	0·3	107	102–116	105	103–114	0·5	0·9
Hip (cm)	106	103–110	106	102–109	0·4	108	105–114	111	105–115	0·4	1·0
Waist:hip ratio	0·90	0·90–1·03	0·95	0·90–1·00	0·6	1·00	0·95–1·05	1·00	0·90–1·00	0·2	0·6
Fat %	29·3	23·6–41·3	28·4	23·0–40·1	0·04	31·0	26·8–33·8	31·5	26·3–33·8	0·8	0·03
Total body fat (kg)	28·8	20·5–34·1	29·0	20·2–32·0	0·09	29·1	24·7–37·2	29·9	25·5–37·7	0·5	0·2
Trunk fat (kg)	16·0	12·8–19·1	15·1	12·6–19·0	0·05	18·3	15·3–21·3	17·9	15·8–21·0	0·4	0·04
FFM (kg)	63·8	47·0–69·1	65·1	48·5–71·0	0·02	70·2	60·6–74·8	70·3	60·7–73·9	0·8	0·06
Fat %:weight ratio	0·31	0·26–0·52	0·30	0·26–0·49	0·02	0·30	0·27–0·37	0·28	0·27–0·36	0·5	0·03

ALA, α-linolenic acid; DAG, diacylglycerol; BP, blood pressure; FFM, fat-free mass.

* Within the high-ALA-DAG group (prior to Bonferroni correction).

† Within the high-ALA-TAG group (prior to Bonferroni correction).

‡ Comparing change from baseline to the end of the study between the high-ALA-DAG and high-ALA-TAG groups (prior to Bonferroni correction).